Opinion ID: 785067
Heading Depth: 4
Heading Rank: 1

Heading: schedule i.

Text: 29 (A) The drug or other substance has a high potential for abuse. 30 (B) The drug or other substance has no currently accepted medical use in treatment in the United States. 31 (C) There is a lack of accepted safety for use of the drug or other substance under medical supervision. 32 The DEA does not purport to have met the requirements for placement of non-psychoactive hemp on Schedule I, and indeed disclaims any need to show that non-psychoactive hemp has a high potential for abuse. Instead, the DEA argues that naturally-occurring THC in those parts of the hemp plant excluded from the definition of marijuana have always been included under the listing for THC, and that it had no previous need to clarify this because the intentional use of such products in foodstuffs is relatively new within the United States. The DEA urges that under Chevron its definition of the meaning of THC in the CSA should be given deference. However, no deference is required because this issue is resolved at Chevron step one: the statutory language on point unambiguously precludes an interpretation of the THC definition that includes non-psychoactive hemp.